OVERVIEW
The market size for cancer patient registry software is calculated to reach USD 96.21 million by 2024, growing over the forecast period at a CAGR of 10.5%. The growth of this market is driven by factors such as the increasing prevalence of cancer, favorable government initiatives, increased adoption of EHRs, and increased use of cancer registry data for post-marketing surveillance.
TABLE OF CONTENT
1 Global Cancer Registry Software Market
1.1 Study Objectives
1.2 Market Definition
1.3 Study Scope
1.3.1 Markets Covered
1.3.2 Geographic Scope
2 RESEARCH METHODOLOGY
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Key Industry Insights
2.1.2.3 Breakdown of Primaries
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.2 Top-Down Approach
2.3 Market Breakdown and Data Triangulation
2.4 Research Assumptions
3 Global Cancer Registry Software Market – Executive Summary
3.1 Market Revenue, Market Size and Key Trends by Company
3.2 Key Trends by type of Application
3.3 Key Trends segmented by Geography
4 Global Cancer Registry Software Market – Comparative Analysis
4.1 Product Benchmarking – Top 10 companies
4.2 Top 5 Financials Analysis
4.3 Market Value split by Top 10 companies
4.4 Patent Analysis – Top 10 companies
4.5 Pricing Analysis
5 Global Cancer Registry Software Market – Industry Market Entry Scenario
5.1 Regulatory Framework Overview
5.2 New Business and Ease of Doing business index
5.3 Case studies of successful ventures
5.4 Customer Analysis – Top 10 companies
6 Global Cancer Registry Software Market – Market Forces
6.1 Introduction
6.2 Market Dynamics
6.2.1 Drivers
6.2.2 Opportunities
6.2.3 Challenges
6.3 Porters Analysis of Market
6.3.1 Bargaining power of suppliers
6.3.2 Bargaining powers of customers
6.3.3 Threat of new entrants
6.3.4 Rivalry among existing players
6.3.5 Threat of substitutes
7 Global Cancer Registry Software Market – Strategic Analysis
7.1 Value Chain analysis
7.2 Product Life Cycle
7.3 Supplier and distributor analysis (Market share and product dealing strategies)
8 Global Cancer Registry Software Market – By Type (Market Size – & million/billion)
8.1 Standalone Software
8.2 Integrated Software
9 Global Cancer Registry Software Market – By Delivery Model
9.1 On-premise
9.2 Cloud-based
10 Global Cancer Registry Software Market – By Database
10.1 Commercial Databases
10.2 Public Databases
11 Global Cancer Registry Software Market – By Functionality
11.1 Cancer Reporting to Meet State & Federal Regulations
11.2 Patient Care Management
11.3 Product Outcome Evaluation
11.4 Medical Research and Clinical Studies
12 Global Cancer Registry Software Market – By End-User
12.1 Government Organizations & Third-party Administrators (TPAS)
12.2 Hospitals & Medical Practices
12.3 Pharmaceutical, Biotechnology, & Medical Device Companies
12.4 Private Payers
12.5 Research Centers
13 Global Cancer Registry Software Market – By Geography (Market Size – & million/billion)
13.1 Introduction
13.2 North America
13.2.1 US
13.2.2 Canada
13.2.3 Mexico
13.3 Europe
13.3.1 U.K
13.3.2 Germany
13.3.3 Italy
13.3.4 France
13.3.5 Spain
13.3.6 Rest of Europe
13.4 Asia-Pacific
13.4.1 China
13.4.2 Japan
13.4.3 India
13.4.4 South Korea
13.4.5 Rest of APAC
13.5 Rest of the World
13.5.1 South America
13.5.2 Middle East
13.5.3 Africa
14 Global Cancer Registry Software Market – Entropy
14.1 New product launches
14.2 M&A's, collaborations, JVs and partnerships
15 Global Cancer Registry Software Market Company Profile (Key Players)
15.1 Market Share, Company Revenue, Products, M&A, Developments
15.2 Onco, Inc.
15.3 C/Net Solutions
15.4 Elekta AB (PUB)
15.5 Electronic Registry Systems, Inc.
15.6 Mckesson Corporation
15.7 Rocky Mountain Cancer Data Systems
15.8 Company 7
15.9 Company 8
15.10 Company 9
15.11 Company 10
15.12 Company 11 & more
16 Global Cancer Registry Software Market – Appendix
16.1 Sources
16.2 Abbreviations